BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37524011)

  • 1. The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women.
    Braga A; Lopes R; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; de Sousa CB; Leal E; Yela D; Uberti E; Madi JM; Viggiano M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Sep; 176():130-138. PubMed ID: 37524011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study.
    Freitas F; Braga A; Viggiano M; Velarde LGC; Maesta I; Uberti E; Madi JM; Yela D; Fernandes K; Silveira E; Leal E; Sun SY; Dos Santos Esteves APV; Filho JR; Junior JA; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2020 Aug; 158(2):452-459. PubMed ID: 32402634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
    Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
    Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lung metastasis on the treatment and prognosis of patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
    Zhang T; Guo Y; He X; Hou M; Wang L; An R; Gao L
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):636-644. PubMed ID: 38282348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America.
    Maestá I; de Freitas Segalla Moreira M; Rezende-Filho J; Bianconi MI; Jankilevich G; Otero S; Correa Ramirez LA; Sun SY; Elias K; Horowitz N; Braga A; Berkowitz R
    Int J Gynecol Cancer; 2020 Sep; 30(9):1366-1371. PubMed ID: 32376739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017.
    Kong Y; Zong L; Cheng H; Jiang F; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Cancer Med; 2020 Apr; 9(7):2590-2599. PubMed ID: 32022487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia.
    Clark LH; Staley SA; Barber EL; Wysham WZ; Kim KH; Soper JT
    Am J Obstet Gynecol; 2016 Aug; 215(2):217.e1-5. PubMed ID: 26875944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
    Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y
    Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
    Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
    Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy.
    Jareemit N; Horowitz NS; Goldstein DP; Berkowitz RS; Elias KM
    Gynecol Oncol; 2020 Dec; 159(3):751-757. PubMed ID: 33023756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of chest CT scan in gestational trophoblastic neoplasia with lung metastasis].
    Cheng Y; Ma FH; Wang XR; Le XN; Zhang GF; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):384-389. PubMed ID: 29961280
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia.
    Braga A; Canelas AC; Torres B; Maesta I; Giongo Pedrotti L; Bessel M; Vieira Dos Santos Esteves AP; Amim Junior J; Rezende Filho J; Elias KM; Horowitz NS; Berkowitz RS
    PLoS One; 2022; 17(12):e0277892. PubMed ID: 36454778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.
    Braga A; de Souza Hartung Araújo C; Mora PAR; Paulino E; de Melo AC; Velarde GC; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2020 Mar; 156(3):598-605. PubMed ID: 31928806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
    Oranratanaphan S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia.
    Singhal S; Kumar L; Kumar S; Khurana S; Bhatla N
    Indian J Med Res; 2020 Dec; 152(6):595-606. PubMed ID: 34145099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.